FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Fluorescein Injection
Status: Currently in Shortage
»Date first posted: 05/30/2018
»Therapeutic Categories: Ophthalmology

Expand all

Akorn Pharmaceuticals (New 05/30/2018)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
AK-FLUOR® (fluorescein injection, USP) 10%, 100 mg/mL in a 5 mL single use vial (NDC 17478-253-10) Unavailable Expected availability August 2018 Shortage of an active ingredient
AK-FLUOR® (fluorescein injection, USP) 25%, 250 mg/mL in a 2 mL single use vial (NDC 17478-250-20) Unavailable Expected availability August 2018 Shortage of an active ingredient

Novartis (New 06/15/2018)

Company Contact Information:
888-669-6682

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Fluorescite (fluorescein injection) 10% 5 mL vial (NDC 0065-0092-65) Available Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English